CB1 cannabinoid receptors inhibit the glutamatergic component of KCl-evoked excitation of locus coeruleus neurons in rat brain slices

Neuropharmacology

Volumn 52, Issue 2, 2007, Pages 617-625

  Mendiguren, Aitziber ^a   Pineda, Joseba ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

CNQX; D AP5; KCl; Locus coeruleus; Single unit extracellular recording; WIN 55212 2

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 AMINO 5 PHOSPHONOVALERIC ACID; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PICROTOXIN; POTASSIUM CHLORIDE;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GABAERGIC TRANSMISSION; HISTOGRAM; LOCUS CERULEUS; MALE; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE UNIT ACTIVITY; SYNAPTIC INHIBITION;

ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGENTS; GABA ANTAGONISTS; GLUTAMIC ACID; LOCUS COERULEUS; MALE; MORPHOLINES; NAPHTHALENES; NEURAL INHIBITION; NEURONS; PICROTOXIN; PIPERIDINES; POTASSIUM CHLORIDE; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; TIME FACTORS;

EID: 33846464995     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.09.004     Document Type: Article

References (51)

1. Andrade R., Vandermaelen C.P., and Aghajanian G.K. Morphine tolerance and dependence in the locus coeruleus: single cell studies in brain slices. Eur. J. Pharmacol. 91 (1983) 161-169
2. Aston-Jones G., Rajkowski J., and Cohen J. Role of locus coeruleus in attention and behavioural flexibility. Biol. Psychiatry 46 (1999) 1309-1320
3. Aston-Jones G., Ennis M., Pieribone V.A., Nickell W.T., and Shipley M.T. The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network. Science 234 (1986) 734-737
4. + and glutamate activates different neurotransmitter release mechanisms in GABAergic neurons: vesicular versus non-vesicular release of GABA. Neuroscience 54 (1993) 1019-1034
5. Berridge C.W., and Waterhouse B.D. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res. Rev. 42 (2003) 33-84
6. Cannizzaro C., D'Amico M., Preziosi P., and Martire M. Presynaptic effects of anandamide and WIN55,212-2 on glutamatergic nerve endings isolated from rat hippocampus. Neurochem. Int. 48 (2006) 159-165
7. Chadha A., Sur C., Atack J., and Duty S. The 5-HT(1B) receptor agonist, CP-93129, inhibits [(3)H]-GABA release from rat globus pallidus slices and reverses akinesia following intrapallidal injection in the reserpine-treated rat. Br. J. Pharmacol. 130 (2000) 1927-1932
8. Cherubini E., North R.A., and Williams J.T. Synaptic potentials in rat locus coeruleus neurones. J. Physiol. 406 (1988) 431-442
9. Egan T.M., Henderson G., North R.A., and Williams J.T. Noradrenaline-mediated synaptic inhibition in rat locus coeruleus neurones. J. Physiol. 345 (1983) 477-488
10. Freund T.F., Katona I., and Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83 (2003) 1017-1066
11. Gobbi G., Bambico F.R., Mangieri R., Bortolato M., Campolongo P., Solinas M., Cassano T., Morgese M.G., Debonnel G., Duranti A., Tontini A., Tarzia G., Mor M., Trezza V., Goldberg S.R., Cuomo V., and Piomelli D. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 18620-18625
12. + channels but not changes in cAMP signaling contribute to the inhibition of glutamate release by cannabinoid receptors in cerebrocortical nerve terminals. Neuropharmacology 48 (2005) 547-557
13. Gutierrez T., Nackley A.G., Neely M.H., Freeman K.G., Edwards G.L., and Hohmann A.G. Effects of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinociception in models of acute and tonic nociception. Brain Res. 987 (2003) 176-185
14. Hajos N., Katona I., Naiem S.S., MacKie K., Ledent C., Mody I., and Freund T.F. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur. J. Neurosci. 12 (2000) 3239-3249
15. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., De Costa B.R., and Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11 (1991) 563-583
16. Hoffman A.F., and Lupica C.R. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J. Neurosci. 20 (2000) 2470-2479
17. Hoffman A.F., and Lupica C.R. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J. Neurophysiol. 85 (2001) 72-83
18. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., and Pertwee R.G. XXVII. International Union of Pharmacology. Classification of Cannabinoid receptors. Pharmacol. Rev. 54 (2002) 161-202
19. Jentsch J.D., Andrusiak E., Tran A., Bowers Jr. M.B., and Roth R.H. Delta 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966. Neuropsychopharmacology 16 (1997) 426-432
20. Kataoka Y., Ohta H., Fujiwara M., Oishi R., and Ueki S. Noradrenergic involvement in catalepsy induced by delta9-tetrahydrocannabinol. Neuropharmacology 26 (1987) 55-60
21. Katona I., Sperlagh B., Sik A., Kafalvi A., Vizi E.S., Mackie K., and Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19 (1999) 4544-4558
22. Kofalvi A., Rodrigues R.J., Ledent C., Mackie K., Viz E.S., Cunha R.A., and Sperlagh B. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. J. Neurosci. 25 (2005) 2874-2884
23. Lerma J. Roles and rules of kainate receptors in synaptic transmission. Nat. Rev. Neurosci. 4 (2003) 481-495
24. Liachenko S., Tang P., Somogyi G.T., and Xu Y. Concentration-dependent isoflurane effects on depolarization-evoked glutamate and GABA outflows from mouse brain slices. Br. J. Pharmacol. 127 (1999) 131-134
25. Margalit D., and Segal M. A pharmacologic study of analgesia produced by stimulation of the nucleus locus coeruleus. Psychopharmacology 62 (1979) 169-173
26. Matsuda L.A., Bonner T.I., and Lolait S.J. Localization of cannabinoid receptor mRNA in rat brain. Comp. Neurol. 327 (1993) 535-550
27. Melis M., Pistis M., Perra S., Muntoni A.L., Pillolla G., and Gessa G.L. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J. Neurosci. 24 (2004) 53-62
28. Mendiguren A., and Pineda J. Cannabinoids enhance N-methyl-D-aspartate-induced excitation of locus coeruleus neurons by CB1 receptors in rat brain slices. Neurosci. Lett. 363 (2004) 1-5
29. Mendiguren A., and Pineda J. Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats. Eur. J. Pharmacol. 534 (2006) 83-88
30. Moranta D., Esteban S., and Garcia-Sevilla J.A. Differential effects of acute cannabinoid drug treatment, mediated by CB1 receptors, on the in vivo activity of tyrosine and tryptophan hydroxylase in the rat brain. Naunym-Schmiedeberg's Arch. Pharmacol. 369 (2004) 516-524
31. Muntoni A.L., Pillolla G., Melis M., Perra S., Gessa G.L., and Pistis M. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. Eur. J. Neurosci. 23 (2006) 2385-2394
32. Nestler E.J., and Aghajanian G.K. Molecular and cellular basis of addiction. Science 278 (1997) 58-63
33. Nowak L., Bregestovski P., Ascher P., Herbet A., and Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307 (1984) 462-465
34. Oropeza, V.C., Peoples, J.F., Mackie, K., Van Bockstaele, E.J., 2001. Ultrastructural analysis of the cannabinoid receptor (CB1) in rat noradrenergic locus coeruleus (LC) in rat brain. Soc. Neurosci. Abstr 27. Program No. 668.15.
35. Oropeza V.C., Page M.E., and Van Bockstaele E.J. Systemic administration of WIN 55212-2 increases norepinephrine release in the rat frontal cortex. Brain Res. 1046 (2005) 45-54
36. Osmanovic S.S., and Shefner S.A. Gamma-Aminobutyric acid responses in rat locus coeruleus neurones in vitro: a current-clamp and voltage-clamp study. J. Physiol. 421 (1990) 151-170
37. Paquet M., and Smith Y. Presynaptic NMDA receptor subunit immunoreactivity in GABAergic terminals in rat brain. J. Comp. Neurol. 423 (2000) 330-347
38. Patel S., and Hillard C.J. Cannabinoid-induced Fos expression within A10 dopaminergic neurons. Brain Res. 963 (2003) 15-25
39. Pineda J., Kogan J.H., and Aghajanian G.K. Nitric oxide and carbon monoxide activate locus coeruleus neurons through a cGMP-dependent protein kinase: involvement of a nonselective cationic channel. J. Neurosci. 16 (1996) 1389-1399
40. Riegel A.C., and Lupica C.R. Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J. Neurosci. 24 (2004) 11070-11078
41. Schlicker E., and Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 22 (2001) 565-572
42. Singh P.P., and Das P.K. Role of catecholamines in the hypothermic activity of cannabis in albino rats. Psychopharmacology 50 (1976) 199-204
43. Sved A.F., Cano G., Passerin A.M., and Rabin B.S. The locus coeruleus, Barrington's nucleus, and neural circuits of stress. Physiol. Behav. 77 (2002) 737-742
44. Szabo B., and Schlicker E. Effects of cannabinoids on neurotransmission. In: Pertwee R. (Ed). Cannabinoids, Handbook of Experimental Pharmacology vol. 168 (2005), Springer, Berlin 328-357
45. Szabo B., Dorner L., Pfreundtner C., Norenberg W., and Starke K. Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience 85 (1998) 395-403
46. Szabo B., Siemes S., and Wallmichrath I. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur. J. Neurosci. 15 (2002) 2057-2061
47. 2+ and glutamate release. J. Neurochem. 53 (1989) 1693-1699
48. Tsou K., Brown S., Sanudo-Peña M.C., Mackie K., and Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83 (1998) 393-411
49. Van Bockstaele E.J., and Colago E.E. Selective distribution of the NMDA-R1 glutamate receptor in astrocytes and presynaptic axon terminals in the nucleus locus coeruleus of the rat brain: an immunoelectron microscopic study. J. Comp. Neurol. 369 (1996) 483-496
50. Vaughan C.W., Connor M., Bagley E.E., and Christie M.J. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. Mol. Pharmacol. 57 (2000) 288-295
51. Williams J.T., Bobker D.H., and Harris G.C. Synaptic potentials in the locus coeruleus neurons in brain slices. Prog. Brain Res. 88 (1991) 167-172